These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26303702)

  • 1. Biochemical Testing in Patients with Neuroendocrine Tumors.
    Granberg D
    Front Horm Res; 2015; 44():24-39. PubMed ID: 26303702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical diagnosis of neuroendocrine GEP tumor.
    Oberg K
    Yale J Biol Med; 1997; 70(5-6):501-8. PubMed ID: 9825477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in neuroendocrine tumors.
    Eriksson B; Oberg K; Stridsberg M
    Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.
    Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R
    Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
    Metz DC
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour markers in neuroendocrine tumours.
    Oberg K; Janson ET; Eriksson B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic endocrine tumors.
    Oberg K
    Semin Oncol; 2010 Dec; 37(6):594-618. PubMed ID: 21167379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
    Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.
    Wermers RA; Fatourechi V; Kvols LK
    Mayo Clin Proc; 1996 Nov; 71(11):1030-8. PubMed ID: 8917287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of pancreatic neuroendocrine tumors.
    Grozinsky-Glasberg S; Mazeh H; Gross DJ
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):578-85. PubMed ID: 25689919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Kanakis G; Kaltsas G
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumors.
    Batcher E; Madaj P; Gianoukakis AG
    Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neuroendocrine Neoplasms of the Digestive Tract: Diagnosis, Treatment and Nutrition.
    Pobłocki J; Jasińska A; Syrenicz A; Andrysiak-Mamos E; Szczuko M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic endocrine tumors: recent advances.
    Jensen RT
    Ann Oncol; 1999; 10 Suppl 4():170-6. PubMed ID: 10436815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's syndrome in patients with the Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    N Engl J Med; 1986 Jul; 315(1):1-5. PubMed ID: 2872593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of endocrine pancreatic tumours.
    Akerström G; Hellman P; Hessman O; Osmak L
    Neuroendocrinology; 2004; 80 Suppl 1():62-6. PubMed ID: 15477720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors.
    Bretherton-Watt D; Ghatei MA; Bloom SE; Williams S; Bloom SR
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1072-4. PubMed ID: 8473384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.